A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer
暂无分享,去创建一个
A.G.Z. Eriksson | G. Gardner | M. Leitao | R. Soslow | Y. Sonoda | O. Zivanovic | A. Beavis | Qin Zhou | N. Abu-Rustum | K. L. Long Roche | E. Jewell | Qin C Zhou | A. Eriksson
[1] A. Ferenczy,et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.
[2] J. Sehouli,et al. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer , 2015, Archives of Gynecology and Obstetrics.
[3] D. Levine,et al. Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery , 2015, Annals of Surgical Oncology.
[4] A. Weaver,et al. Multicenter study assessing the detection of stage IIIC endometrial cancer in intermediate- and high-risk tumors between a contemporary sentinel node mapping versus historical comprehensive lymphadenectomy approach , 2015 .
[5] A. Fader,et al. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. , 2014, Gynecologic oncology.
[6] Douglas A Levine,et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. , 2014, Gynecologic oncology.
[7] N. Abu-Rustum. Update on sentinel node mapping in uterine cancer: 10‐year experience at Memorial Sloan–Kettering Cancer Center , 2014, The journal of obstetrics and gynaecology research.
[8] R. Barakat,et al. Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging , 2013, International Journal of Gynecologic Cancer.
[9] L. Haas,et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. , 2012, Gynecologic oncology.
[10] R. Barakat,et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. , 2012, Gynecologic oncology.
[11] R. Rouzier,et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). , 2011, The Lancet. Oncology.
[12] D. Levine,et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? , 2009, Gynecologic oncology.
[13] R. Barakat,et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. , 2009, Gynecologic oncology.
[14] V. Torri,et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.
[15] M. Parmar,et al. Lymphadenectomy in endometrial cancer – Authors' reply , 2009, The Lancet.
[16] M. Parmar,et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.
[17] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .